WMT

115.61

+0.1%↑

COST

862.58

+0.25%↑

147.6

+1.56%↑

70.56

+0.14%↑

158.47

+0.16%↑

WMT

115.61

+0.1%↑

COST

862.58

+0.25%↑

147.6

+1.56%↑

70.56

+0.14%↑

158.47

+0.16%↑

WMT

115.61

+0.1%↑

COST

862.58

+0.25%↑

147.6

+1.56%↑

70.56

+0.14%↑

158.47

+0.16%↑

WMT

115.61

+0.1%↑

COST

862.58

+0.25%↑

147.6

+1.56%↑

70.56

+0.14%↑

158.47

+0.16%↑

WMT

115.61

+0.1%↑

COST

862.58

+0.25%↑

147.6

+1.56%↑

70.56

+0.14%↑

158.47

+0.16%↑

Home・Akcijų sąrašas・USANA Health Sciences Inc

USANA Health Sciences Inc

Uždarymo kaina

20.44 1.04

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

20.03

Max

20.6

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-17M -6.7M
Pardavimai	-22M 214M
P/E Sektoriaus vid.	22.578 28.862
Pelnas, tenkantis vienai akcijai	-0.15
Pelno marža	-3.118
Darbuotojai	1,700
EBITDA	-17M 11M

Rekomendacijos
By TipRanks
Rekomendacijos	Neutralu
12 mėnesių prognozė	+91.83% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-10M 371M
Ankstesnė atidarymo kaina	19.4
Ankstesnė uždarymo kaina	20.44

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

28.405 / 29.84 Palaikymas ir pasipriešinimas

USANA Health Sciences Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-17 23:50; UTC

Karštos akcijos

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

2025-12-17 23:20; UTC

Uždarbis

Correction to Micron Logs Sales Jump Article

2025-12-17 23:07; UTC

Uždarbis

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

2025-12-17 21:37; UTC

Uždarbis

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

2025-12-17 23:53; UTC

Rinkos pokalbiai

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

2025-12-17 23:43; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

2025-12-17 23:06; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

2025-12-17 23:05; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

2025-12-17 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

2025-12-17 23:03; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

2025-12-17 23:02; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

2025-12-17 22:59; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

2025-12-17 22:57; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

2025-12-17 22:56; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

2025-12-17 22:55; UTC

Įsigijimai, susijungimai, perėmimai

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

2025-12-17 22:49; UTC

Rinkos pokalbiai

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

2025-12-17 21:58; UTC

Uždarbis

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

2025-12-17 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-17 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-17 21:46; UTC

Uždarbis

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

2025-12-17 21:20; UTC

Uždarbis

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

2025-12-17 21:10; UTC

Uždarbis

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

2025-12-17 21:05; UTC

Uždarbis

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

2025-12-17 21:04; UTC

Uždarbis

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

2025-12-17 21:04; UTC

Uždarbis

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

2025-12-17 21:03; UTC

Uždarbis

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

2025-12-17 21:03; UTC

Uždarbis

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

2025-12-17 21:03; UTC

Uždarbis

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

2025-12-17 21:02; UTC

Uždarbis

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

2025-12-17 21:01; UTC

Uždarbis

Micron Technology 1Q Rev $13.64B >MU

Akcijų palyginimas

Kainos pokytis

USANA Health Sciences Inc Prognozė

Kainos tikslas

By TipRanks

91.83% į viršų

12 mėnesių prognozė

Vidutinis 39 USD 91.83%

Aukščiausias 39 USD

Žemiausias 39 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines USANA Health Sciences Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių USANA Health Sciences Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

28.405 / 29.84Palaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.